Monopar Therapeutics (MNPR) Cash from Financing Activities (2017 - 2025)
Monopar Therapeutics' Cash from Financing Activities was -$384,680 in Q4 2025, compared with $56.14 million a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Cash from Financing Activities (2017 - 2025) Analysis & Trends
For FY2025, Cash from Financing Activities at Monopar Therapeutics came in at $91.57 million, up 54.4% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of 62.1% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $59.29 million in FY2024, $2.03 million in FY2023, $32,873 in FY2022 (-99.7%) and $10.88 million in FY2021 (+33.0%).
- The Q4 2025 figure marks the lowest quarterly Cash from Financing Activities in data going back to Q1 2017.
- Per Business Quant data, MNPR's Cash from Financing Activities in the three quarters before Q4 2025 was $92.39 million (Q3 2025), -$316,845 (Q2 2025) and -$115,682 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Monopar Therapeutics | 680.58 Mn | 398.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -384,680.00 |
| Sep 30, 2025 | 92.39 Mn |
| Jun 30, 2025 | -316,845.00 |
| Mar 31, 2025 | -115,682.00 |
| Dec 31, 2024 | 56.14 Mn |
| Sep 30, 2024 | -16,534.00 |
| Jun 30, 2024 | -9,919.00 |
| Mar 31, 2024 | 3.18 Mn |
| Dec 31, 2023 | 334,548.00 |
| Sep 30, 2023 | 246,703.00 |
| Jun 30, 2023 | 641,178.00 |
| Mar 31, 2023 | 804,798.00 |
| Dec 31, 2022 | 138,737.00 |
| Sep 30, 2022 | -23,738.00 |
| Jun 30, 2022 | -65,460.00 |
| Mar 31, 2022 | -16,666.00 |
| Dec 31, 2021 | -7,772.00 |
| Sep 30, 2021 | -9,978.00 |
| Jun 30, 2021 | -24,003.00 |
| Mar 31, 2021 | 10.92 Mn |
API Access
Monopar Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();